172 related articles for article (PubMed ID: 2088204)
1. In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
Yajko DM; Sanders CA; Nassos PS; Hadley WK
Antimicrob Agents Chemother; 1990 Dec; 34(12):2442-4. PubMed ID: 2088204
[TBL] [Abstract][Full Text] [Related]
2. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
[TBL] [Abstract][Full Text] [Related]
3. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method.
Tomioka H; Saito H; Fujii K; Sato K; Hidaka T
Antimicrob Agents Chemother; 1993 Jan; 37(1):67-70. PubMed ID: 8431020
[TBL] [Abstract][Full Text] [Related]
5. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
6. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
7. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Gevaudan MJ; Bollet C; Mallet MN; de Micco P
J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
[TBL] [Abstract][Full Text] [Related]
8. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
[TBL] [Abstract][Full Text] [Related]
9. French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex.
Rastogi N; Bauriaud RM; Bourgoin A; Carbonnelle B; Chippaux C; Gevaudan MJ; Goh KS; Moinard D; Roos P
Antimicrob Agents Chemother; 1995 Mar; 39(3):638-44. PubMed ID: 7793865
[TBL] [Abstract][Full Text] [Related]
10. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ
Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860
[TBL] [Abstract][Full Text] [Related]
11. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
[TBL] [Abstract][Full Text] [Related]
12. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
Klopman G; Fercu D; Renau TE; Jacobs MR
Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
[TBL] [Abstract][Full Text] [Related]
13. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.
Yajko DM; Kirihara J; Sanders C; Nassos P; Hadley WK
Antimicrob Agents Chemother; 1988 Sep; 32(9):1392-5. PubMed ID: 3196000
[TBL] [Abstract][Full Text] [Related]
15. Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Sirgel FA; Venter A; Heilmann HD
J Antimicrob Chemother; 1995 Feb; 35(2):349-51. PubMed ID: 7759400
[No Abstract] [Full Text] [Related]
16. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
Barrett MS; Jones RN; Erwin ME; Koontz FP
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
[TBL] [Abstract][Full Text] [Related]
18. In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
Kaur D; Khuller GK
Int J Antimicrob Agents; 2001 Jan; 17(1):51-5. PubMed ID: 11137649
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
